Published in Proc Natl Acad Sci U S A on November 01, 1971
Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins. Proc Natl Acad Sci U S A (1971) 2.17
Myeloma proteins as tumor-specific transplantation antigens. Proc Natl Acad Sci U S A (1972) 2.09
Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element. J Virol (1989) 2.07
Localization of antibody-combining sites within the variable portions of heavy and light chains. Proc Natl Acad Sci U S A (1972) 1.84
Transcription in vitro of immunoglobulin kappa light chain genes in isolated mouse myeloma nuclei and chromatin. Proc Natl Acad Sci U S A (1976) 1.38
Amino-acid sequence of the variable region of the heavy (alpha) chain of a mouse myeloma protein with anti-hapten activity. Proc Natl Acad Sci U S A (1974) 1.36
Identification of a third type of lambda light chain in mouse immunoglobulins. Proc Natl Acad Sci U S A (1981) 1.31
Localization of idiotypic antigenic determinants in the Fv region of murine myeloma protein MOPC-315. Proc Natl Acad Sci U S A (1973) 1.24
The natural abundance of lambda2-light chains in inbred mice. J Exp Med (1978) 1.23
Cell-bound myeloma proteins on the surface of myeloma cells: potential targets for the immune system. Proc Natl Acad Sci U S A (1972) 1.20
Reaction of anti-idiotypic antibody with the hapten-binding site of a myeloma protein. Proc Natl Acad Sci U S A (1971) 1.09
Lambda2 light chains in normal mouse immunoglobulins. Proc Natl Acad Sci U S A (1978) 1.03
Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells. Proc Natl Acad Sci U S A (2000) 0.96
An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med (1970) 9.83
Variability in the lambda light chain sequences of mouse antibody. Nature (1970) 5.71
Evidence for control of synthesis of the varible regions of the heavy chains of immunoglobulins G and M by the same gene. Proc Natl Acad Sci U S A (1970) 2.96
The antibody problem. Annu Rev Biochem (1969) 2.88
Mechanism of antibody synthesis: size differences between mouse kappa chains. Science (1967) 2.77
Amino acid sequences of two mouse immunoglobulin lambda chains. Proc Natl Acad Sci U S A (1971) 2.12
Specificity of recombination of H and L chains from human gamma-G-myeloma proteins. J Exp Med (1965) 1.69
Immunochemical studies of the reaction between a mouse myeloma macroglobulin and dextrans. Biochemistry (1970) 1.68
Subgroups of amino acid sequences in the variable regions of immunoglobulin heavy chains. Proc Natl Acad Sci U S A (1969) 1.67
Macroglobulin structure: homology of mu and gamma heavy chains of human immunoglobulins. Science (1969) 1.64
Amino acid sequence analysis with methyl isothiocyanate. Resolution of the methylthiohydantoins by gas-liquid partition chromatography. Biochemistry (1970) 1.61
Mouse myelomas producing precipitating antibody to nucleic acid bases and-or nitrophenyl derivatives. Nature (1968) 1.56
Experimental approaches to homogenous antibody populations. Factors controlling the occurrence of antibodies with uniform properties. Fed Proc (1970) 1.51
Experimental approaches to homogenous antibody populations. Myeloma proteins with antihapten antibody activity. Fed Proc (1970) 1.51
Association of allotypic specificities of group a with allotypic specificities A11 and A12 in rabbit immunoglobulin. Biochemistry (1970) 1.43
Evidence for multiple gene control of a single polypeptide chain: the heavy chain of rabbit immunoglobulin. Proc Natl Acad Sci U S A (1969) 1.38
Separation of the alpha and beta-chains of human hemoglobin. Nature (1968) 1.37
Experimental approaches to homogenous antibody populations. Mouse IgA myeloma proteins that bind polysaccharide antigens of enterobacterial origin. Fed Proc (1970) 1.29
Two types of lambda polypeptide chains in human immunoglobulins based on an amino acid substitution at position 190. Proc Natl Acad Sci U S A (1967) 1.29
Antibodies of restricted heterogeneity for structural study. Fed Proc (1970) 1.24
The amino acid sequence of bovine carboxypeptidase A. II. Tryptic and chymotryptic peptides of the cyanogen bromide fragment F-III. Biochemistry (1969) 1.18
Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Sequence and position of a labeled tryptic peptide. Biochemistry (1970) 1.17
Nonallelic behavior of the Oz groups in human lambda immunoglobulin chains. Proc Natl Acad Sci U S A (1968) 1.13
Automatic systems for detecting cystine and cystinyl peptides during column chromatography. Anal Biochem (1970) 0.93
Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages. J Exp Med (1975) 5.19
Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. Nature (1984) 5.19
ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEIC ACID. III. THE INCORPORATION OF PYRIMIDINE AND PURINE ANALOGUES INTO DEOXYRIBONUCLEIC ACID. Proc Natl Acad Sci U S A (1958) 4.99
Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315. Biochemistry (1968) 4.83
Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity (1996) 4.68
Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med (2000) 4.54
Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria. Biochim Biophys Acta (1972) 4.45
EXCITATION ENERGY TRANSFER AND THE QUANTITATIVE STUDY OF THE ANTIBODY HAPTEN REACTION. Proc Natl Acad Sci U S A (1960) 4.43
Structure, organization, and somatic rearrangement of T cell gamma genes. Cell (1985) 3.49
A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes. Nature (1984) 3.46
Polypeptide growth factors. Annu Rev Biochem (1984) 2.88
Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med (1994) 2.81
Origins of MIT inquiry. Nature (1991) 2.81
Characterization and use of monoclonal antibodies for isolation of phosphotyrosyl proteins from retrovirus-transformed cells and growth factor-stimulated cells. Mol Cell Biol (1983) 2.70
Limited diversity of the rearranged T-cell gamma gene. Nature (1985) 2.58
Nerve growth factor from mouse submaxillary gland: amino acid sequence. Proc Natl Acad Sci U S A (1971) 2.55
Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc Natl Acad Sci U S A (1984) 2.54
A novel serine esterase expressed by cytotoxic T lymphocytes. Nature (1985) 2.43
Kinetic and affinity limits on antibodies produced during immune responses. Proc Natl Acad Sci U S A (1995) 2.41
Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity (1994) 2.39
Amino acid sequence of Escherichia coli alkaline phosphatase. Proc Natl Acad Sci U S A (1981) 2.35
A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell (1992) 2.34
The relative affinity of antibodies synthesized in the secondary response. J Exp Med (1967) 2.33
Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1984) 2.32
Amino acid sequence of the light chain of a mouse myeloma protein (MOPC-315). Biochemistry (1973) 2.30
ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEIC ACID. IV. LINKAGE OF SINGLE DEOXYNUCLEOTIDES TO THE DEOXYNUCLEOSIDE ENDS OF DEOXYRIBONUCLEIC ACID. Proc Natl Acad Sci U S A (1958) 2.27
An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc Natl Acad Sci U S A (1991) 2.26
Preparation and characterization of antibodies specific for the 2,4,6-trinitrophenyl group. Biochemistry (1966) 2.20
ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEIC ACID. V. CHEMICAL COMPOSITION OF ENZYMATICALLY SYNTHESIZED DEOXYRIBONUCLEIC ACID. Proc Natl Acad Sci U S A (1958) 2.18
Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins. Proc Natl Acad Sci U S A (1971) 2.17
A DEMONSTRATION OF ANTIBODY ACTIVITY ON MICROSOMES. Proc Natl Acad Sci U S A (1959) 2.12
Myeloma proteins as tumor-specific transplantation antigens. Proc Natl Acad Sci U S A (1972) 2.09
High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci U S A (1994) 2.09
Phosphotyrosine-containing proteins isolated by affinity chromatography with antibodies to a synthetic hapten. Nature (1981) 2.08
Cotranslational processing and protein turnover in eukaryotic cells. Biochemistry (1988) 2.07
Studies of the mechanism of tunicamycin in hibition of IgA and IgE secretion by plasma cells. J Biol Chem (1977) 2.06
Nerve growth factor and insulin. Science (1972) 2.06
Specificity of cotranslational amino-terminal processing of proteins in yeast. Biochemistry (1987) 1.95
Functional differences between memory and naive CD8 T cells. Proc Natl Acad Sci U S A (1999) 1.94
Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. J Immunol (1995) 1.91
Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1978) 1.88
Lack of Fc-epsilon receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood (1997) 1.86
Primary structural requirements for the enzymatic formation of the N-glycosidic bond in glycoproteins. Studies with natural and synthetic peptides. J Biol Chem (1979) 1.85
Serine esterase in cytolytic T lymphocytes. Nature (1986) 1.85
Comparison of myoglobins from harbor seal, porpoise, and sperm whale. I. Preparation and characterization. J Biol Chem (1968) 1.83
Secondary, tertiary, and quaternary structure of T-cell-specific immunoglobulin-like polypeptide chains. Proc Natl Acad Sci U S A (1986) 1.81
Sequential changes in the relative affinity of antibodies synthesized during the immune response. J Exp Med (1967) 1.80
Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc Natl Acad Sci U S A (1986) 1.79
Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. Proc Natl Acad Sci U S A (1995) 1.76
Amino acid sequence homology among the 2-hydroxy acid dehydrogenases: mitochondrial and cytoplasmic malate dehydrogenases form a homologous system with lactate dehydrogenase. Proc Natl Acad Sci U S A (1982) 1.69
Properties of the specific binding of 125I-nerve growth factor to responsive peripheral neurons. J Biol Chem (1974) 1.68
Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. EMBO J (1994) 1.68
Subunit structure and number of combining sites of the immunoglobulin A myeloma protein produced by mouse plasmacytoma MOPC-315. Biochemistry (1971) 1.68
Immunofluorescence studies of neurofilaments in the rat and human peripheral and central nervous system. J Cell Biol (1977) 1.65
Symposium on in vitro studies of the immune response. I. Variations in the immune response to a simple determinant. Bacteriol Rev (1966) 1.65
Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation. Immunol Rev (1979) 1.64
A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. Proc Natl Acad Sci U S A (1993) 1.63
Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci U S A (1990) 1.63
Bovine fibroblast growth factor: comparison of brain and pituitary preparations. J Cell Biol (1982) 1.61
Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/ MHC epitopes and strength of their interaction with T cell receptors. Proc Natl Acad Sci U S A (2001) 1.61
The amino acid sequence of bovine carboxypeptidase A. Proc Natl Acad Sci U S A (1969) 1.56
Antibodies to idiotypes of isologous immunoglobulins. J Exp Med (1975) 1.56
Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia. Cancer Res (1974) 1.52
Amino acid sequence of Escherichia coli alkaline phosphatase. Amino- and carboxyl-terminal sequences and variations between two isozymes. Biochemistry (1973) 1.51
Experimental approaches to homogenous antibody populations. Myeloma proteins with antihapten antibody activity. Fed Proc (1970) 1.51
Myeloma proteins with anti-hapten antibody activity: epsilon-2,4-dinitrophenyl lysine binding by the protein produced by mouse plasmacytoma MOPC-460. J Immunol (1969) 1.51
Calcium ion concentrations and DNA fragmentation in target cell destruction by murine cloned cytotoxic T lymphocytes. J Exp Med (1988) 1.49
Topography of mouse 2.5S nerve growth factor. Reactivity of tyrosine and tryptophan. Biochemistry (1973) 1.48
The immune response to a simple antigenic determinant. Harvey Lect (1966) 1.47
Amino acid sequences of mouse 2.5S nerve growth factor. II. Isolation and characterization of the thermolytic and peptic peptides and the complete covalent structure. Biochemistry (1973) 1.47
Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. Immunity (1998) 1.46
Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci U S A (1997) 1.46
Specificity of the immune response to the 2,4-dinitrophenyl and 2,4,6-trinitrophenyl groups. Ligand binding and fluorescence properties of cross-reacting antibodies. J Exp Med (1969) 1.44
The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1995) 1.43
Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc Natl Acad Sci U S A (1990) 1.41
Effects of N alpha-tosyl-L-lysyl-chloromethylketone on the activity of cytotoxic T lymphocytes. J Immunol (1980) 1.39
Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J Immunol (1996) 1.39
Amino acid sequence of L-3-hydroxyacyl CoA dehydrogenase from pig heart muscle. FEBS Lett (1980) 1.36
Amino-acid sequence of the variable region of the heavy (alpha) chain of a mouse myeloma protein with anti-hapten activity. Proc Natl Acad Sci U S A (1974) 1.36
Subunit structure and amino acid composition of mouse submaxillary gland nerve growth factor. Biochemistry (1971) 1.36
The amino acid sequence of peptide (1-24) of rat and human serum albumins. J Biol Chem (1969) 1.35
NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J Neurosci (2000) 1.35
Brain fibroblast growth factor: nonidentity with myelin basic protein fragments. J Biol Chem (1980) 1.34
Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes. Proc Natl Acad Sci U S A (1975) 1.33
Adenomatoid Transformation of the Glomerular Capsular Epithelium. Am J Pathol (1946) 1.33
Structural and functional similarities between mitochondrial malate dehydrogenase and L-3-hydroxyacyl CoA dehydrogenase. Proc Natl Acad Sci U S A (1974) 1.33
Specificity and structure of the myeloma protein produced by mouse plasmacytoma MOPC-460. Biochemistry (1971) 1.32
Synthetic phospholipid vesicles containing a purified viral antigen and cell membrane proteins stimulate the development of cytotoxic T lymphocytes. J Exp Med (1979) 1.31
Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells. Proc Natl Acad Sci U S A (1992) 1.31
Identification of a third type of lambda light chain in mouse immunoglobulins. Proc Natl Acad Sci U S A (1981) 1.31